Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.

about

Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.

Item

http://www.wikidata.org/entity/Q49792134

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Elevated Plasma Moxifloxacin C ...... s with Pulmonary Tuberculosis.

@en

Elevated Plasma Moxifloxacin C ...... s with Pulmonary Tuberculosis.

@nl

type

Item

label

Elevated Plasma Moxifloxacin C ...... s with Pulmonary Tuberculosis.

@en

Elevated Plasma Moxifloxacin C ...... s with Pulmonary Tuberculosis.

@nl

prefLabel

Elevated Plasma Moxifloxacin C ...... s with Pulmonary Tuberculosis.

@en

Elevated Plasma Moxifloxacin C ...... s with Pulmonary Tuberculosis.

@nl

P1476

Elevated Plasma Moxifloxacin C ...... s with Pulmonary Tuberculosis.

@en

P2093

Charles A Peloquin

http://www.w3.org/2001/XMLSchema#string

Erin E Sizemore

http://www.w3.org/2001/XMLSchema#string

John L Johnson

http://www.w3.org/2001/XMLSchema#string

Jon Gelfond

http://www.w3.org/2001/XMLSchema#string

Marc Weiner

http://www.w3.org/2001/XMLSchema#string

Melissa Engle

http://www.w3.org/2001/XMLSchema#string

Teresa L Johnson-Pais

http://www.w3.org/2001/XMLSchema#string

William R Mac Kenzie

http://www.w3.org/2001/XMLSchema#string

P2860

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.

The effect of moxifloxacin on QTc and implications for the design of thorough QT studies.

Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations.

Moxifloxacin safety: an analysis of 14 years of clinical data.

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.

QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

Pharmacogenomics of human UDP-glucuronosyltransferase enzymes.

P31

scholarly article

P356

10.1128/AAC.01802-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29463526

http://www.w3.org/2001/XMLSchema#string

P932

5923103

http://www.w3.org/2001/XMLSchema#string